# Mycophenolate Mofetil for the Prophylaxis of Graft-versus-host Disease in High Risk Allogeneic Stem Cell Transplantation

> **NCT00563589** · NA · UNKNOWN · sponsor: **Hospital Authority, Hong Kong** · enrollment: 30 (estimated)

## Conditions studied

- Graft vs Host Disease
- Hematopoietic Stem Cell Transplantation

## Interventions

- **DRUG:** mycophenolate mofetil, methotrexate, cyclosporin
- **DRUG:** Methotrexate and cyclosporin

## Key facts

- **NCT ID:** NCT00563589
- **Lead sponsor:** Hospital Authority, Hong Kong
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2003-08
- **Primary completion:** —
- **Final completion:** 2008-12
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2010-07-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00563589

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00563589, "Mycophenolate Mofetil for the Prophylaxis of Graft-versus-host Disease in High Risk Allogeneic Stem Cell Transplantation". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00563589. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*